Skip to content

VERDE BIO HOLDINGS, INC.: 10-Q filed 2019-10-01

What VERDE BIO HOLDINGS, INC. reported in its quarterly report filed 2019-10-01 (fiscal Q2 2019): 23 published measures, 76 facts as tagged in accession 0001445866-19-001192.

This filing

Form
10-Q (quarterly report)
Filed
2019-10-01
Fiscal period
fiscal Q2 2019
Accession
0001445866-19-001192 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VERDE BIO HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2018-10-314,473USD
At 2018-04-3023,799USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2018-10-311,270,553USD
At 2018-04-301,548,135USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2018-10-31-1,266,080USD
At 2018-07-31-1,143,723USD
At 2018-04-30-1,524,336USD
At 2017-10-31-909,444USD
At 2017-07-31-987,397USD
At 2017-04-30-1,549,285USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2018-05-01 to 2018-10-31-5,656USD184
2017-05-01 to 2017-10-31-167,800USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2018-08-01 to 2018-10-310USD92
2018-05-01 to 2018-10-310USD184
2017-08-01 to 2017-10-3116,800USD92
2017-05-01 to 2017-10-3127,900USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2018-05-01 to 2018-10-310USD184
2017-05-01 to 2017-10-31158,000USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2018-10-31-5,205,711USD
At 2018-04-30-5,409,251USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2018-08-01 to 2018-10-31107,425,498shares92
2018-05-01 to 2018-10-3196,291,606shares184
2017-08-01 to 2017-10-317,660,299shares92
2017-05-01 to 2017-10-316,137,685shares184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2018-08-01 to 2018-10-31107,425,498shares92
2018-05-01 to 2018-10-31939,004,106shares184
2017-08-01 to 2017-10-317,660,299shares92
2017-05-01 to 2017-10-316,137,685shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2018-08-01 to 2018-10-310USD/shares92
2018-05-01 to 2018-10-310USD/shares184
2017-08-01 to 2017-10-31-0.05USD/shares92
2017-05-01 to 2017-10-31-0.08USD/shares184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2018-08-01 to 2018-10-310USD/shares92
2018-05-01 to 2018-10-310USD/shares184
2017-08-01 to 2017-10-31-0.05USD/shares92
2017-05-01 to 2017-10-31-0.08USD/shares184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2018-08-01 to 2018-10-31-6,865USD92
2018-05-01 to 2018-10-31-27,091USD184
2017-08-01 to 2017-10-31-102,427USD92
2017-05-01 to 2017-10-31-276,284USD184

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2018-08-01 to 2018-10-31111,191USD92
2018-05-01 to 2018-10-31176,292USD184
2017-08-01 to 2017-10-3187,056USD92
2017-05-01 to 2017-10-31131,483USD184

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2018-10-310USD
At 2018-04-305,051USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2018-08-01 to 2018-10-316,865USD92
2018-05-01 to 2018-10-3127,091USD184
2017-08-01 to 2017-10-31109,537USD92
2017-05-01 to 2017-10-31289,487USD184

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2018-08-01 to 2018-10-310USD92
2018-05-01 to 2018-10-310USD184
2017-08-01 to 2017-10-317,110USD92
2017-05-01 to 2017-10-3113,203USD184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2018-08-01 to 2018-10-310USD92
2018-05-01 to 2018-10-310USD184
2017-08-01 to 2017-10-319,690USD92
2017-05-01 to 2017-10-3114,697USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2018-10-31107,425,498shares
At 2018-04-3062,866,385shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2018-10-313,831,706USD
At 2018-04-303,821,541USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2018-08-01 to 2018-10-31-122,357USD92
2018-05-01 to 2018-10-31203,540USD184
2017-08-01 to 2017-10-31-380,217USD92
2017-05-01 to 2017-10-31-464,749USD184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2018-08-01 to 2018-10-315,037USD92
2018-05-01 to 2018-10-3113,421USD184
2017-08-01 to 2017-10-3127,134USD92
2017-05-01 to 2017-10-3166,281USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2018-08-01 to 2018-10-31-115,492USD92
2018-05-01 to 2018-10-31230,631USD184
2017-08-01 to 2017-10-31-277,790USD92
2017-05-01 to 2017-10-31-188,465USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2018-05-01 to 2018-10-310USD184
2017-05-01 to 2017-10-3110,531USD184

Inspect the source

Entity
VERDE BIO HOLDINGS, INC. / CIK 0001490054
Captured
SEC response SHA-256
dd7cd08239c5c2462afbc7dbecad94ca6a89142a02ded38321628f853eea98c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001490054.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))